It is noteworthy that exosomal lncRNA TBILA (sensitivity of 63.2%) is more sensitive in discriminating early stage of NSCLC than exosomal lncRNA AGAP2-AS1 (sensitivity of 42.1%) and Cyfra21-1 (sensitivity of 36.3%). This evidence concerns the gene TBILA and non-small cell lung carcinoma.